Eli Lilly bets $3.35B on a Chinese biotech's drug discovery platform #EliLilly #InnoCarePharma
Explore
#EliLilly has continued a busy period of #dealmaking with a wide-ranging #partnership with #China's #InnoCarePharma that includes upfront and near-term payments of $100 million.
